Navigation Links
Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry
Date:4/20/2009

NORWOOD, Mass. April 20 /PRNewswire/ -- Advanced Instruments, Inc. today introduced the Advanced(R) 2020-BIO Multi-Sample Osmometer as the first true automation-friendly osmometer for the biopharmaceutical industry.

"The Advanced(R) 2020-BIO Multi-Sample Osmometer is specifically designed for -- and completely redefines -- automation capabilities for osmolality testing in the biopharmaceutical laboratory," said Kelly Peterson, Product Manager, Advanced Instruments (www.aicompanies.com). "The 2020-BIO system development is in response to emerging demand in the pharmaceutical industry to integrate osmolality testing within an automated platform environment."

"Based on an extension of the industry-proven Advanced 2020 Osmometer, the 2020-BIO includes a host of features which enable fast and simple integration of the system with liquid handling robotics and laboratory automation platforms," Peterson said.

The 2020-BIO has been successfully applied to automate osmolality testing in applications ranging from cell culture process development and optimization to biopharmaceutical manufacturing and process control - It can also be extended to pharmaceutical research and drug development applications including formulation development, product stability testing, and drug safety and metabolism testing.

Major features of the new 2020-BIO include:

  • Freezing point technology -- The industry-preferred method for determining sample concentration
  • Automation friendly system design allows easy access for liquid handling robotics
  • Interoperability with a broad range of robotics and liquid handling equipment
  • Flexible system configuration options provide continuous sampling capabilities for enhanced throughput
  • Bidirectional data transfer utilizing the preferred OPC open connectivity protocol
  • Remote system control via an industry-standard RS-232 interface for secure connectivity to a PC.
  • Fast and simple integration -- the developer's kit includes a .DLL for osmometer controls, making automation development easy to achieve.
  • Small 20 microliter sample sizes -- ideal for sample-limited applications or for sharing sample volume with other integrated systems.

"The bottom line is that the 2020-BIO is the only commercially available system that provides fast, accurate osmolality testing in an automation friendly package," Peterson said.

The Advanced(R) 2020-BIO Multi-Sample Osmometer from Advanced Instruments is available immediately for shipment in the United States and Canada. For more information, visit the Advanced Instruments website at www.aicompanies.com/2020-BIO, or call 1-800-225-4034 or 1-781-320-9000.

About Advanced Instruments, Inc.

Founded in 1955, Advanced Instruments, Inc. (www.aicompanies.com) is the world's largest supplier of freezing-point cryoscopes and osmometers used in dairy, clinical, pharmaceutical, and biotechnology laboratories. The company is also a leading supplier of analytical instruments for the food and industrial microbiology markets. Based in Norwood, Massachusetts, USA, the privately held company also produces Fiske(R) Associates brand diagnostic instruments and operates Spiral Biotech, Inc., D&F Control Systems, Inc., Mart Microbiology, and Delta Instruments as wholly-owned subsidiaries. A worldwide network of direct sales people and independent distributors supports Advanced Instruments' products.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Kelly D. Peterson

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=79271


'/>"/>
SOURCE Advanced Instruments, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):